ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Keyword Index

Click a keyword to view all the abstracts on this site tagged with that keyword.

  • systemic sclerosis and weight loss
  • systemic sclerosis and wounds
  • systemic sclerosis and x-ray
  • systemic score
  • Systemic treatmen
  • systemic vasculitides
  • systemic vasculitides and auto-immunity
  • systemic vasculitides and Biologic agents
  • systemic vasculitides and biologic drugs
  • systemic vasculitides and thrombosis
  • systemic vasculitides and vasculitis
  • Systems-based Studies
  • sytemic sclerosis
  • T Cell
  • T cell and immune checkpoint inibitor
  • T cell exhaustion
  • T cell repertoire
  • T cells
  • T cells and abatacept
  • T cells and animal models
  • T cells and ankylosing spondylitis (AS)
  • T cells and antigen-presenting cells
  • T cells and arthritis
  • T cells and aspirin
  • T cells and atherosclerosis
  • T cells and auto-immunity
  • T cells and autoimmune diseases
  • T cells and autoimmunity
  • T cells and Autoinflammatory Disease
  • T cells and B cells
  • T cells and catecholamines
  • T cells and chemokines
  • T cells and co-stimulation
  • T cells and Crohn's Disease
  • T cells and cytokines
  • T cells and dendritic cells
  • T cells and dermatomyositis
  • T cells and Early Rheumatoid Arthritis
  • T cells and epigenetics
  • T cells and flow cytometry
  • T cells and genetics
  • T cells and giant cell arteritis
  • T cells and granulomatosis with polyangiitis
  • T cells and hematopoietic stem cells
  • T cells and Histone Modification
  • T cells and hormones
  • T cells and immune response
  • T cells and immunoglobulin (IG)
  • T cells and innate immunity
  • T cells and interferons
  • T cells and interleukins (IL)
  • T cells and juvenile dermatomyositis
  • T cells and juvenile spondylarthropathy
  • T cells and kinase
  • T cells and Lupus
  • T cells and metabolism
  • T cells and methylation
  • T cells and monoclonal antibodies
  • T cells and myositis
  • T cells and nephritis
  • T cells and neuropsychiatric disorders
  • T cells and osteoarthritis
  • T cells and osteoclastogenesis
  • T cells and osteoclasts
  • T cells and pathogenesis
  • T cells and rheumatoid arthritis
  • T cells and rheumatoid arthritis (RA)
  • T cells and rituximab
  • T cells and salivary gland
  • T cells and shared epitope
  • T cells and signal transduction
  • T cells and spondylarthritis
  • T cells and spondylarthropathy
  • T cells and syk
  • T cells and synovium
  • T cells and systemic lupus erythematosus (SLE)
  • T cells and systemic sclerosis
  • T cells and t reg
  • T cells and T-Regulatory Cells
  • T cells and takayasu arteritis
  • T cells and Telomeres
  • T cells and therapeutic targeting
  • T cells and transcription factor
  • T cells and transcriptional regulation
  • T cells and treatment
  • T cells and tyrosine kinase inhibition
  • T cells and vasculitis
  • T cells and Wegener's granulomatosis
  • T lymphocytes
  • T peripheral cells
  • T regulatory subsets
  • T-Lymphocyte
  • T-Regulatory Cells
  • T-Regulatory Cells and arthritis
  • T-Regulatory Cells and auto-immunity
  • T-Regulatory Cells and autoimmune diseases
  • T-Regulatory Cells and autoimmunity
  • T-Regulatory Cells and Behcet's syndrome
  • T-Regulatory Cells and cytokines
  • T-Regulatory Cells and dendritic cells
  • T-Regulatory Cells and epigenetics
  • T-Regulatory Cells and immune deficiency
  • T-Regulatory Cells and interleukins (IL)
  • T-Regulatory Cells and juvenile arthritis
  • T-Regulatory Cells and kinase
  • T-Regulatory Cells and lupus nephritis
  • T-Regulatory Cells and methotrexate (MTX)
  • T-Regulatory Cells and mouse model
  • T-Regulatory Cells and osteoclastogenesis
  • T-Regulatory Cells and pathogenesis
  • T-Regulatory Cells and pediatric rheumatology
  • T-Regulatory Cells and rheumatoid arthritis
  • T-Regulatory Cells and rheumatoid arthritis (RA)
  • T-Regulatory Cells and systemic lupus erythematosus (SLE)
  • T-Regulatory Cells and treatment
  • T-Regulatory Cells and vasculitis
  • T1Rho quantitative imaging
  • T2 imaging and imaging standardization
  • T2t
  • TACI and autoantibodies
  • TACI and mouse model
  • TACI and toll-like receptors
  • Tacrolimus
  • tacrolimus and malignancy
  • tacrolimus and transplantation
  • tacrolimus and treatment
  • tai chi
  • tai chi and yoga
  • tailored intervention
  • Takayasu arteritis
  • takayasu arteritis and comorbidity
  • takayasu arteritis and giant cell arteritis
  • takayasu arteritis and pediatric rheumatology
  • takayasu arteritis and positron emission tomography (PET)
  • takayasu arteritis and pregnancy
  • takayasu arteritis and tocilizumab
  • takayasu arteritis and treatment
  • takayasu arteritis and ultrasonography
  • takayasu arteritis and uveitis
  • takayasu arteritis and vasculitis
  • Takayasu.s arteritis
  • Takayasu.s arteritis and arteriosclerosis
  • Takayasu.s arteritis and death
  • Takayasu.s arteritis and giant cell arteritis
  • Takayasu.s arteritis and human leukocyte antigens (HLA)
  • Takayasu.s arteritis and outcomes
  • Takayasu.s arteritis and pregnancy
  • Takayasu.s arteritis and vasculitis
  • taper and rheumatoid arthritis (RA)
  • tapering
  • Targeted synthetic disease-modifyig anti-rheumatic drug
  • targeted therapy selection
  • tbs
  • tbs and gums
  • tbs and nutrition
  • TCR
  • TCR sequencing
  • Techniques
  • Technology
  • technology and vasculitis
  • Telehealth
  • telemedicine
  • Telerheumatology
  • Telomeres
  • Telomeres and hand disorders
  • Telomeres and rheumatoid arthritis (RA)
  • Temporal arteritis
  • temporal arteritis and biopsy
  • temporal arteritis and fast track clinic
  • temporal arteritis and systemic vasculitides
  • temporal arteritis and tobacco use
  • temporal arteritis and tocilizumab
  • temporal arteritis and ultrasonography
  • Temporal arteritis and ultrasound
  • temporal arteritis and vasculitis
  • temporal artery biopsy
  • Temporomandibular joint
  • temporomandibular joint and tracking
  • temporomandibular joint and ultrasound
  • tendon
  • Tendonitis/bursitis
  • tendonitis/bursitis and synovial fluid
  • tendonitis/bursitis and therapy
  • tendonitis/bursitis and treatment options
  • tendonitis/bursitis and ultrasonography
  • tendonitis/bursitis and ultrasound
  • tendonitis/bursitis and wrist
  • tendons
  • tenosynovitis and age
  • TENS
  • test
  • test and tocilizumab
  • test and tuberculosis
  • test and uric acid
  • Tfh cells
  • tgfb
  • Th17
  • Th17 and drug retention
  • TH17 and Treg
  • TH17 Cells
  • First |
  • « Previous Page
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • [63]
  • 64
  • 65
  • 66
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology